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ABSTRACT
Thessu71allelesoftheTFG1gene,whichencodesthe
largestsubunitofTFIIF,wereisolatedassuppressors
ofaTFIIBdefectthataffectstheaccuracyoftranscrip-
tion start site selection in the yeast Saccharomyces
cerevisiae. Here we report that ssu71-1 also sup-
presses the cell growth and start site defects associ-
ated with an altered form of the Rpb1 subunit of RNA
polymerase II (RNAP II). The ssu71-1 and ssu71-2
alleles were cloned and found to encode single
amino acid replacements of glycine-363, either
glycinetoasparticacid(G363D)orglycinetoarginine
(G363R). Two other charged replacements, G363E
and G363K, were constructed by site-directed muta-
genesis and suppress both TFIIB E62K and Rpb1
N445S, whereas neither G363A nor G363P exhibited
anyeffect.G363isphylogeneticallyconservedandits
counterpart in human TFIIF (RAP74 G112) is located
within the RAP74/RAP30 dimerization domain. We
proposethatthe TFIIF dimerizationdomainis located
in proximity to the B-finger of TFIIB near the active
centerofRNAPIIwheretheTFIIB–TFIIF–RNAPIIinter-
face plays a key role in start site selection.
INTRODUCTION
Promoter-dependent transcription by RNA polymerase II
(RNAP II) requires a set of general transcription factors
that include the TATA-binding protein (TBP), TFIIB,
TFIIE, TFIIF and TFIIH (1–3). TBP binds to the TATA
element of promoter DNA to nucleate assembly of the
preinitiation complex (PIC), followed by binding of TFIIB
both upstream and downstream of TATA. The DNA–TBP–
TFIIB ternary complex forms the binding site for RNAP II,
which enters the complex inassociationwith TFIIF.TFIIE and
TFIIH complete PIC assembly and are required for ATP-
dependent promoter melting by RNAP II (4). These steps
deﬁne the pathway of PIC assembly in vitro. A similar path-
way might be followed in vivo as PIC formation has been
shown to proceed via formation of structural intermediates
in yeast (5).
RNAP II comprises 12 subunits, encoded by the RPB1–
RPB12 genes in Saccharomyces cerevisiae (6,7). The Rpb1,
Rpb2, Rpb3 and Rpb11 subunits form the catalytic core of
RNAP II and are the counterpart of the bacterial a2bb0 RNAP
core enzyme. High-resolution X-ray structures of 10- (lacking
Rpb4/Rpb7) and 12-subunit yeast RNAP II complexes
have been solved (8–10), as have minimal transcript elonga-
tion complexes (11–13). These structures, in combination
with high-resolution structures of bacterial RNAPs (14),
offer insight into the mechanism of transcription and a
framework for the interpretation of a wealth of genetic and
biochemical data.
TFIIB plays a key role in transcription initiation. The SUA7
gene, which encodes yeast TFIIB, was initially identiﬁed by
mutations that alter start site selection (15). The sua7-1 and
sua7-3alleles shiftinitiationattheCYC1andADH1promoters
downstream of normal and encode, respectively, glutamate-62
to lysine (E62K) and arginine-78 to cysteine (R78C) replace-
ments (16). TFIIB E62 replacements do not affect PIC assem-
bly, but abolish transcription in vitro by adversely affecting
RNAP II promoter clearance (5,17,18). The N-terminal
domain of TFIIB forms a zinc-ribbon that interacts with
TFIIF and the ‘dock’ domain of RNAP II (19,20). A phylo-
genetically conserved domain lies immediately downstream of
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doi:10.1093/nar/gki825the zinc-ribbon and is critical for accurate start site selection
in yeast (2), human (21) and Archaea (22). The recent
high-resolution X-ray structure of a yeast RNAP II–TFIIB
complex deﬁned the conserved domain as a ‘B-ﬁnger’ that
encompasses E62 and R78. The B-ﬁnger projects into the
RNAP II active center via the ‘saddle’ between the ‘clamp’
and ‘wall’ domains (20). This structure suggests that steric
clash between the B-ﬁnger and nascent RNA on the saddle
accounts for abortive initiation (20), a proposal consistent
with the effect of the R78C replacement on promoter
clearance (18).
The same genetic selection that yielded the sua7 mutants
yielded the sua8 alleles of RPB1 (23). The sua7 and sua8
mutants confer similar growth defects, show identical effects
on start site selection and a double sua7-1 sua8-1 mutant is
synthetically lethal. These results deﬁne a functional interac-
tion between Rpb1 and TFIIB, and imply that this interaction
is critical for accurate initiation. The sua8-1 allele encodes an
asparagine-445 to serine (N445S) replacement in the active
center of Rpb1, which is near the B-ﬁnger in the RNAP
II–TFIIB complex (20,23).
TFIIF also affects start site selection. Yeast TFIIF is
composed of three subunits: Tfg1, Tfg2 and Tfg3. Tfg1 and
Tfg2 are counterparts of human TFIIF subunits RAP74 and
RAP30; Tfg3 has no counterpart in mammalian TFIIF, but is
identical to the conserved TAF14 subunit of TFIID (24). A
role for TFIIF in start site selection was uncovered in a genetic
selection for suppressors of the cold-sensitive growth defect
associated with the sua7-1-encoded TFIIB E62K replacement:
two alleles of tfg1 (ssu71-1 and ssu71-2) not only suppressed
the sua7-1 cell growth defect, but also partially restored the
normal pattern of start site selection (25). More recently, two
amino acid replacements in Tfg1 (E346A and W350A) and
a single replacement in Tfg2 (L59K) were reported to shift
initiation at the ADH1 gene upstream of normal in a SUA7
wild-type strain (26). Thus, TFIIB and TFIIF are critical
determinants of start site selection in S.cerevisiae. However,
the mechanism(s) by which altered forms of these factors
affect start site selection remains unresolved.
In an effort to elucidate the mechanism of start site selection
by yeast RNAP II and to determine how mutations in com-
ponents of the transcription initiation machinery alter start
sites, we have deﬁned the ssu71-encoded TFIIF mutations
and analyzed these replacements in the context of crystal
structures of yeast RNAP II–TFIIB and human TFIIF com-
plexes. Our results suggest that the Tfg1–Tfg2 dimer interface
of TFIIF is located within the active center of RNAP II ini-
tiation complex.
MATERIALS AND METHODS
Yeast strains and nomenclature
The yeast strains used in this study are listed in Table 1.
Plasmid-shufﬂe strains YMH904 (SUA7 tfg1::kanMX4
[TFG1-URA3]), YMH910 (sua7-1 tfg1::kanMX4 [TFG1-
URA3]) and YMH916 (sua8-1 tfg1::LEU2 [TFG1-URA3])
were derived from isogenic strains T16 (SUA7), YDW546
(sua7-1) and YDW383 (sua8-1), respectively. The TRP1
gene was ﬁrst disrupted by one-step disruption with either
trp1::hphMX4 (T16, YDW546) or trp1::kanMX6
(YDW383), which were generated by PCR ampliﬁcation of
the drug-resistant cassettes pAG34-hphMX4 (27) or pFA6a-
kanMX6 (28) with primer pairs carrying TRP1 50- and 30-tails.
Strains were then transformed with plasmid pM435 (TFG1-
URA3), followed by one-step disruption of the chromosomal
TFG1 gene either with tfg1::LEU2 (sua8-1) using a
tfg1::LEU2 DNA fragment that was generated by
Table 1. List of yeast strains
Strain Genotype* Reference
T16 MATa cyc1-5000 cyc7-67 leu2-3,112 ura3-52 cyh2 (15)
YDW546 MATa cyc1-5000 cyc7-67 leu2-3,112 ura3 -52 cyh2 sua7-1 (15)
YDW383 MATa cyc1-5000 cyc7-67 leu2-3,112 ura3 -52 cyh2 sua8-1 (23)
YMH71-9C MATa cyc1-5000 cyc7-67 trp5-48 his5-2 ura3-52 sua7-1 (16)
YZS14 MATa cyc1-5000 cyc7-67 trp5-48 his5-2 ura3 -52 sua7 -1 ssu71-1 (25)
YZS45 MATa cyc1-5000 cyc7-67 trp5-48 his5-2 ura3 sua7-1 ssu71 -2 (25)
YZS96 MATa cyc1-5000 cyc7-67 leu2-3,112 ura3-52 cyh2 sua8-1 tfg1::LEU2 [pM482: ssu71-1-URA3] this study
YMH904 MATa cyc1-5000 cyc7-67 ura3-52 leu2 -3,112 cyh2trp1::hphMX4tfg1::kanMX4 [pM435: TFG1
+-URA3 -CEN] this study
YMH905 MATa cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 trp1::hphMX4 tfg1::kanMX4 [pM441: TFG1
+-TRP1-CEN] this study
YMH906 MATa cyc1-5000 cyc7-67 ura3-52 leu2 -3,112 cyh2 trp1::hphMX4 tfg1::kanMX4 [pM1874: tfg1-G363D-TRP1-CEN] this study
YMH907 MATa cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 trp1::hphMX4 tfg1::kanMX4 [pM1876: tfg1-G363E-TRP1-CEN] this study
YMH908 MATa cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 trp1::hphMX4 tfg1::kanMX4 [pM1877: tfg1-G363K-TRP1-CEN] this study
YMH909 MATa cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 trp1::hphMX4 tfg1::kanMX4 [pM1875: tfg1-G363R-TRP1-CEN] this study
YMH910 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua7-1 trp1::hphMX4 tfg1::kanMX4 [pM435: TFG1
+-URA3-CEN] this study
YMH911 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua7-1 trp1::hphMX4 tfg1::kanMX4 [pM441: TFG1
+-TRP1-CEN] this study
YMH912 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua7-1 trp1::hphMX4 tfg1::kanMX4 [pM1874: tfg1-G363D-TRP1-CEN] this study
YMH913 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua7-1 trp1::hphMX4 tfg1::kanMX4 [pM1876: tfg1-G363E-TRP1-CEN] this study
YMH914 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua7-1 trp1::hphMX4 tfg1::kanMX4 [pM1877: tfg1-G363K-TRP1-CEN] this study
YMH915 MATa_cyc1-5000 cyc7-67 ura3-52 leu2 -3,112 cyh2 sua7-1 trp1::hphMX4 tfg1::kanMX4 [pM1875:tfg1-G363R-TRP1-CEN] this study
YMH916 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua8-1 trp1::kanMX tfg1::LEU2 [pM435: TFG1
+-URA3 -CEN] this study
YMH917 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua8-1 trp1::kanMX tfg1::LEU2 [pM441: TFG1
+- TRP1-CEN] this study
YMH918 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua8-1 trp1::kanMX tfg1::LEU2 [pM1874: tfg1-G363D-TRP1-CEN] this study
YMH919 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua8-1 trp1::kanMX tfg1::LEU2 [pM1876: tfg1-G363E-TRP1-CEN this study
YMH920 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua8-1 trp1::kanMX tfg1::LEU2 [pM1877: tfg1-G363K-TRP1-CEN] this study
YMH921 MATa_cyc1-5000 cyc7-67 ura3-52 leu2-3,112 cyh2 sua8-1 trp1::kanMX tfg1::LEU2 [pM1876: tfg1-G363R-TRP1-CEN] this study
*The symbol ssu71 or tfg1 denotes alleles of TFG1.
5046 Nucleic Acids Research, 2005, Vol. 33, No. 16KpnI–SphI digestion of plasmid pM521 or with tfg1::kanMX6
(WT and sua7-1), which was generated from pFA6a-kanMX6
using TFG1-tailed primer pairs. Derivatives of YMH904,
YMH910 and YMH916 that carry plasmid-borne TFG1
+ or
tfg1 alleles encoding G363 replacements were generated by
transformation of the respective strains with either pM441
(TFG1
+-TRP1)orsite-directedderivativesofpM441encoding
TFG1 G363 replacements, followed by counter-selection of
pM435 (TFG1-URA3) on 5-FOA medium. Strain YZS96
(sua8-1 tfg1::LEU2 [tfg1-G363D]) was constructed by
transformation of YDW383 with plasmid pM482 [tfg1-
G363D-URA3], followed by one-step disruption of TFG1,
using plasmid pM521, as described above.
Standard yeast nomenclature is used throughout to desig-
nate genotypes and phenotypes. The symbol ssu71 denotes the
original alleles of the TFG1 gene (25). The symbols Csm
 
(cold sensitive) and Tsm
  (heat sensitive) refer to impaired
growth on yeast extract/peptone/dextrose (YPD) medium at 16
and 37 C, respectively, relative to growth on YPD at 30 C.
YPD, synthetic complete (SC) and SC lacking inositol
(SC–Ino) media were prepared using standard recipes (29).
Site-directed mutagenesis of TFG1
Site-directed mutations in the TFG1 gene were made by the
QuickChange mutagenesis kit (Stratagene) using plasmid
pM441 (TFG1-TRP1) as template DNA and complementary
primer pairs that encode amino acid replacements at Tfg1
position G363. All sequence changes were conﬁrmed by
DNA sequence analysis using TFG1-speciﬁc primers.
Determination of transcript start site sites
Primer extension was performed as described previously using
total RNA and the ADH1-speciﬁc primer oIP87 (15). Primer
extension products were resolved in a 6% polyacrylamide
DNA sequencing gel and visualized by autoradiography.
Radioactive signals were quantiﬁed using ImageQuant
software (Molecular Dynamics).
Retrieval of the ssu71 alleles by gap repair
The ssu71-1 and ssu71-2 alleles were cloned by gap repair
from strains YZS14 and YZS45, respectively (30). Plasmid
pM436 (TFG1-LEU2-2m) was digested with BamHI and
BglII, thereby creating a sequence gap in the TFG1 open
reading frame (ORF), and introduced into YZS14 and
YZS45. Leu
+ transformants were isolated and shown to retain
the Csm
+andTsm
 suppressorphenotypes.PlasmidDNA was
isolated from each strain and conﬁrmed to include the tfg1
BamHI–BglII DNA fragment; these plasmids were designated
pM484 (ssu71-1) and pM538 (ssu71-2). pM484 and pM538
were reintroduced into YZS14 and YZS45 and the resulting
transformants retained the suppressor phenotypes, consistent
with having isolated the ssu71 suppressor mutations. The
entire BamHI–BglII DNA fragments of pM484 and pM538
were sequenced and a single base pair substitution encoding
different amino acid replacements of the same residue (G363D
and G363R) were identiﬁed for the two clones. The TFG1
ORFs ﬂanking the BamHI–BglII DNA fragment of each allele
were subsequently ampliﬁed by PCR from YZS14 and YZS45
genomic DNA and sequenced in their entirety. No other
sequence changes were found.
Protein sequence and structural analyses
Protein sequence comparisons were performed using the
BLAST algorithm (http://www.ncbi.nlm.nih.gov/BLAST).
TFIIF crystallographic structural information was acquired
through the Protein Data Bank (PDB) (http://www.rcsb.org/
pdb/). Amino acid replacements at position G112 of RAP74
were visualized using PyMol.
RESULTS
The ssu71 suppressors encode Tfg1 G363 amino acid
replacements
Two independent ssu71 mutants were isolated as suppressors
of the Csm
  phenotype associated with sua7-1 (25). The
ssu71-1 and ssu71-2 alleles were retrieved from strains
YZS14 and YZS45 by gap repair. DNA sequence analysis
of the entire ssu71 ORF revealed that both alleles are the
result of single base pair substitutions encoding different
amino acid replacements at the same position in the Tfg1
subunit of TFIIF: ssu71-1 encodes glycine-363 to aspartic
acid (G363D), whereas ssu71-2 encodes glycine-363 to argi-
nine (G363R) (Figure 1A). These two different replacements
of the same residue underscore the importance of position
G363 and point to this region of Tfg1 as playing an important
role in the functional interaction between TFIIB, TFIIF and
RNAP II during transcription start site selection.
Tfg1 G363 lies at the Tfg1/Tfg2 interface
The Tfg1 subunit of yeast TFIIF shows limited amino acid
sequence similarity to the RAP74 subunit of human TFIIF
(24,25). However, alignments based on hydrophobic cluster
analysis suggested that Tfg1 residues 312–441 are structurally
related to region I near the N-terminus of RAP74 (residues 66–
187) (31). This alignment is also supported by domain
searches using the PFam database (32). PFam analysis iden-
tiﬁed a single domain common to S.cerevisiae Tfg1 and its
counterpart in Schizosaccharomyces pombe protein T41039;
no other common domains were identiﬁed (33). These two
regions correspond to residues 318–416 of Tfg1 and residues
121–206 of T41039 (Figure 1B). Accordingly, Tfg1 G363 lies
within the most phylogenetically conserved region Tfg1 and
corresponds to G112 of human RAP74.
An X-ray structure for the RAP74(2-172)/RAP30(2-119)
dimerization domain has been solved to 1.7 A ˚ resolution
for human TFIIF (34). This complex forms a novel ‘triple
barrel’ that has been proposed to form loops and extensions
important for interaction with other components of the PIC.
The RAP74/RAP30 dimer interface comprises b-sheets
b1, b2, b3, b6, b7 and b8 of RAP74 and the corresponding
b-sheets of RAP30 (Figure 1C) (34). G112 of human
RAP74 lies within the b7-sheet at the RAP74/RAP30 interface
(Figure 1B and C). Thus, sequence alignments and
comparison with the human RAP74/RAP30 crystal structure
place G363 at the interface between Tfg1 and Tfg2. These
results suggest that the Tfg1/Tfg2 dimerization region
functionally interacts with TFIIB to affect transcription start
site selection.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5047Tfg1 G363D suppresses the Rpb1 N445S replacement
in the RNAP II active center
Based on the similar growth phenotypes and start site defects
associated with sua7 and sua8 mutants, we asked whether
ssu71-1wouldalsosuppresssua8-1.Thesua8-1allele encodes
an Rpb1 N445S replacement within the active center of RNAP
II (23). An isogenic sua8-1 TFG1/SSU71
+ and sua8-1 ssu71-1
strain pair was constructed as described in the Materials and
Methods. The ssu71-1 allele clearly suppressed sua8-1, result-
ing in comparable growth of the sua7-1 ssu71-1 and sua8-1
ssu71-1 strains at 16 C (Figure 2, 16 C panel). In contrast to
sua7 mutants, sua8 mutants are Ino
  and this phenotype was
also partially suppressed by ssu71-1 (rows 3–5, +Ino and  Ino
panels). Although ssu71-1 acts as a suppressor of the Csm
 
phenotype of sua7-1, it confers a synthetic Tsm
  phenotype in
combination with sua7-1at37 C) (rows 1–3, 37 Cpanel). The
sua8-1 ssu71-1 double mutant also exhibited a synthetic Tsm
 
phenotype, although this effect is more difﬁcult to discern
owing to the inherent Tsm
  phenotype of the sua8-1 primary
mutant (rows 4 and 5, 37 C panel). Thus, Tfg1 G363D
suppresses the growth phenotypes associated with defects in
both TFIIB and Rpb1. Moreover, the location of TFIIB E62
and Rpb1 N445 within the crystal structures of RNAP II and
the RNAP II–TFIIB complex imply that the Tfg1/Tfg2 inter-
face of TFIIF is positioned within the active center of the
RNAP II PIC.
Suppression is specific for Tfg1 G363 charged
residue replacements
In an effort to deﬁne the Tfg1 structural requirements at posi-
tion 363 for suppression of TFIIB and RNAP II defects, we
constructed a TFG1 plasmid-shufﬂe strain in isogenic SUA7,
sua7-1 (E62K) and sua8-1 (N445S) genetic backgrounds and
scored site-directed G363 amino acid replacements for sup-
pression of the sua7-1 and sua8-1 growth phenotypes. Results
are presented in Figure 3. Consistent with the phenotypes of
the original ssu71 suppressor strains, G363D and G363R sup-
pressed the sua7-1 Csm
  phenotype (cf.row 6 with rows 7 and
10 at 16 C), conﬁrming that suppression is due solely to these
replacements. Furthermore, two other charged replacements,
Figure 1. Depiction of the ssu71 suppressor mutations. (A) The ssu71-1 and ssu71-2 alleles encode G363D and G363R replacements, respectively. The gray box
denotes the conserved sequence (residues 318–416) shown in B. (B) Sequence alignment of the conserved region of the Tfg1/RAP74 subunit of TFIIF. Hs, human;
Dm, Drososphila melanogaster; Ce, Caenorhabditis elegans; At, Arabidopsis thaliana; Sp, S.pombe; and Sc, S.cerevisiae. Secondary structures from the human
RAP74 protein are indicated below the sequences. The conserved G363 residue of Tfg1 lies within the b7-sheet and is denoted by the black oval. Black shading
indicates identity with the human sequence; gray shading denotes similarity. This sequence was reproduced from Figure 1 of Funk et al. (33), with permission. (C)
RAP74 G112 (Tfg1 G363) lies within the triple barrel structure of the RAP74–RAP30 interaction domain. RAP30 (residues 2–219) is depicted in red; RAP74
(residues2–172)ingreen;residueG112ishighlightedinyellowandmarkedbytheblackarrow.ThisstructurewascreatedusingPyMolbasedontheX-raystructure
of human RAP74/RAP30 (34).
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  pheno-
type (rows 8 and 9). The interactions with TFIIB were not
identical for all G363 replacements, however, as G363D,
G363K and G363R caused synthetic Tsm
  growth defects
incombination with sua7-1 (rows 7,9and 10 at37 C) whereas
G363E exhibited no synthetic growth defect (row 8). These
suppressor (Csm
 ) and synthetic (Tsm
 ) growth phenotypes
are consistent with those of the original YZS14 and YZS45
strains, which were initially selected based on screening Csm
+
revertants for a Tsm
  phenotype (25). In contrast to the four
charged residue replacements of G363, neither G363A nor
G363P suppressed the sua7-1 Csm
  phenotype (data not
shown).
Although the sua8-1 mutant exhibits a less severe Csm
 
phenotype than the sua7-1 mutant (Figure 3, cf. rows 1, 6 and
11 at 16 C), this phenotype is nonetheless discernable and is
clearly suppressed by all four G363 replacements (cf. row 11
with rows 12–15). Comparable with their effects on sua7-1,
Figure 2. Phenotypes associated with the ssu71-1 suppressor of sua7-1 and sua8-1. The top three panels depict cell growth on YPD medium at the indicated
temperatures.ThebottompanelsdepictgrowthonSCmediumeitherinthepresence(+Ino)orabsence( Ino)ofinositolat30 C.The10-foldserialdilutionsofeach
strain were spotted onto culture plates and photographed after 2 (30 C), 3 (37 C) or 5 (16 C) days of incubation. Strains: 1, YZS14 (sua7-1 ssu71-1); 2, YDW546
(sua7-1); 3, T16 (wt); 4, YDW383 (sua8-1); and 5, YZS96 (sua8-1 ssu71-1).
Figure 3. Growth phenotypes associated with Tfg1 G363 amino acid replacements in the WT, sua7-1 and sua8-1 backgrounds. All strains (Table 1) are isogenic,
differing only by the indicated sua7-1 or sua8-1 alleles and Tfg1 G363 amino acid replacements, D, E, K or R.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5049the G363D, G363K and G363R replacements also enhanced
the sua8-1 Tsm
  defect, resulting in no growth at 37 C. In
contrast, but identical to its effect on sua7-1, G363E has no
effect on sua8-1 at 37 C (cf. rows 11 and 13). These results
underscore the functional importance of Tfg1 residue G363
and suggest that suppression by charged residue replacements
might be a consequence of forming alternative salt bridges
within the RNAP II active center (Discussion).
Effects of Tfg1 G363 amino acid replacements on
transcription start site selection
The sua7-1 and sua8-1 alleles cause the selection of transcrip-
tion start sites to shift downstream of normal in a promoter-
speciﬁc manner (16,23). We therefore asked whether the Tfg1
G363 amino acid replacements also compensate for this
defect. Transcription start sites at the ADH1 gene were
mapped by primer extension. Results are shown in Figure 4.
The sua7-1 and sua8-1 alleles shifted initiation downstream,
as seen by diminishedinitiationat 37and enhancedinitiation
at sites downstream of  27 (cf. lane 1 with lanes 6 and 11).
The acidic G363D and G363E replacements suppressed the
sua7-1 defect, partially restoring the normal ADH1 start site
pattern (lanes 7 and 8). The most notable effects of the basic
G363K and G363R replacements were to diminish the overall
levels of ADH1 transcripts, although these replacements also
weakly compensated for the downstream start site shift asso-
ciated with sua7-1 (cf. lanes 9 and 10 with lane 6).
Somewhat different effects were observed in the sua8-1
background. In this case, the G363D and G363K replacements
weakly compensated for the downstream shift and the princi-
pal effect of the G363K replacement was again to diminish
overall ADH1 transcript levels (cf. lanes 12 and 14 with
lane 11). Conversely, the effects of G363E and G363R on
compensation of the downstream start site shift associated
with sua8-1 were more pronounced (cf. lanes 13 and
15 with lane 11). Furthermore, G363E consistently enhanced
overall ADH1 transcript levels.
In the otherwise wild-type background, the two negatively
charged replacements, G363D and G363E, enhanced initiation
upstream of normal (cf. lane 1 and lanes 2 and 3), whereas
neither of the positively charged replacements had any effect
(lanes 4 and 5). Thus, acidic and basic residue replacements of
Tfg1 G363 exert differential effects on both the accuracy and
level of ADH1 transcription in a manner dependent upon
TFIIB and Rpb1. These results support our conclusion that
the ‘triple barrel’ structure at the Tfg1/Tfg2 interface lies
within the active center of RNAP II where it plays a critical
role in the mechanism of transcription initiation.
DISCUSSION
In this study we have deﬁned charged residue replacements of
G363 in the largest subunit of TFIIF that are responsible for
suppression of the Csm
  growth defects and altered initiation
pattern associated with TFIIB and Rpb1 defects. These results
deﬁne a functional interaction among the TFIIB–Tfg1–Rpb1
components of the PIC and implicate the altered regions of
these three polypeptides in the mechanism of start site selec-
tion.
The topological organization of the yeast RNAP II–TFIIF
complex has been deﬁned by cryo-electron microscopy (35).
The TFIIF electron density was distributed across the surface
of RNAP II and other regions of the complex. Tfg1 was
deduced to interact with the Rpb4–Rpb7 subcomplex and
with the mobile ‘clamp’ that swings over the active center.
These images, however, are not of sufﬁcient resolution to
deﬁne speciﬁc contact points of Tfg1 or Tfg2 with the
RNAP II–TFIIF structure. Our identiﬁcation of Tfg1 G363
replacements as suppressors of start site defects associated
with amino acid replacements of TFIIB and Rpb1 residues,
both of which lie within the active center of the TFIIB–RNAP
II complex, combined with comparative sequence information
that places G363 at the Tfg1–Tfg2 dimer interface, make a
strong case for the TFIIF dimerization region being located
Figure 4. Primer extension analysis of ADH1 transcription start sites. All strains (Table 1) are identical to those definedin Figure 3. In the wild-typestrain (lane 1),
transcriptioninitiatesattwosites, 37and 27(AofATGisdenoted+1),indicatedbythearrows.Startsitesthatareenhancedin themutantandsuppressorstrains
upstream of  37 and downstream of  27 are highlighted by arrow heads. The ratio indicates the amount of transcript at  37 relative to  27. Quantification was
performed using software from the Alpha Imager (Alpha Innotech). All values were normalized to the  37: 27 ratio for the WT strain, which was defined as 1.0.
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Furthermore, these results, and those from the Ponticelli labor-
atory (26), implicate the triple barrel region of TFIIF as a
determinant of start site selection, presumably by interacting
with the B-ﬁnger–Rpb1 interface.
High-resolution protein–DNA contacts have been deter-
mined forthe yeast RNAP II transcription initiationmachinery
(36). The results from that study revealed that Tfg1 and Tfg2
crosslinked to promoter DNA at the transcription start site.
Moreover, the TFIIB R78C replacement, which shifts start site
selection in a manner comparable with TFIIB E62K, has no
effect on TFIIB–DNA interactions, but instead enhances the
crosslinking of Tfg1 and Tfg2 at the start site. These results
offer strong biochemical support for our model placing the
Tfg1–Tfg2 dimer interface within the active center of RNAP II
where it functionally interacts with the B-ﬁnger to affect start
site selection.
How do Tfg1 G363 replacements by positively or nega-
tively charged residues suppress TFIIB E62K? The E62 res-
idue lies within the B-ﬁnger opposite to R78 and appears to
form an E62-R78 salt bridge important for maintaining the
structure of the B-ﬁnger (16,20). E62K and R78C replace-
ments confer similar growth phenotypes and start site defects,
implying that the structural integrity of the B-ﬁnger is critical
for accurate initiation. We suggest that Tfg1 G363 is posi-
tioned within the active center of the PIC where charged
replacements compensate for disruption of the B-ﬁnger E62-
R78 salt bridge, perhaps forming a compensatory salt bridge.
For example, Tfg1 acidic replacements G363D or G363E
might replace TFIIB E62, forming a salt bridge with TFIIB
R78. Conversely, basic residue replacements G363K and
G363R might form a salt bridge with a different, negatively
charged TFIIB residue such as conserved residue D58. In
either case, we propose that alternative salt bridges involving
Tfg1 G363 replacements partially restore the structural
integrity of the B-ﬁnger that is critical for accurate start site
selection.
How then do Tfg1 G363 replacements compensate for Rpb1
N445S? The X-ray structure of an RNAP II elongation
complex revealed that Rpb1 N445 directly contacts the
DNA template strand at positions  1/ 2, immediately
upstream of the active center (11). It is interesting that this
is the precise location where Tfg1 and Tfg2 crosslink to pro-
moter DNA in a DNA–TBP–TFIIB–TFIIF–RNAP II complex
(36). Moreover, these crosslink sites are altered by the TFIIB
R78C replacement. Although this information does not deﬁne
how Tfg1 G363 charges residue replacements suppress Rpb1
N445S it supports our conclusion that the TFIIF dimerization
domain lies within the active center of the RNAP II PIC.
We wish to note that defects distal to the RNAP II active
center canalsoaffect start site selection.An altered form ofthe
Rpb9 subunit of RNAP II was identiﬁed in the same genetic
screen that identiﬁed the Tfg1 G363 suppressors (37). Further-
more, deletion of the RPB9 gene shifted transcription start site
selection upstream of normal at the ADH1 gene in a manner
comparable with the Tfg1 G363 replacements deﬁned here, or
with the Tfg1 E364A and W350A replacements deﬁned pre-
viously (26,37–39). An Rpb2 replacement (G369S) located
near the Rpb9 subunit conferred a similar upstream start
site shift and suppressed the TFIIB R78C defect (18).
These results deﬁne a functional relationship between Rpb9
and its neighboring Rpb2 region with the active center Rpb1–
TFIIB–TFIIF interface. Yet in the crystal structure of yeast
RNAP II the Rpb2–Rpb9 interface forms part of the upper
‘jaw-lobe’ region of RNAP II, which is distal to the active
center (10). This apparent discrepancy can be explained, how-
ever, by impaired TFIIF–RNAP II association conferred by
deletion of Rpb9 (26,39). Accordingly, Rpb9 is likely to play
an indirect role in start site selection by altering interaction of
the triple barrel within the active center of RNAP II, effec-
tively mimicking the structural changes associated with the
Tfg1 W350, G363 and E364 amino acid replacements.
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